Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2003
06/25/2003EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1321151A1 Antiparkinsonism drugs
06/25/2003EP1321146A2 Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use
06/25/2003EP1321143A1 Combination of N-butyldeoxygalactonojirimycin and glycolipid degrading enzyme in therapy
06/25/2003EP1321140A1 Ibuprofen solutions for capsule-filling and capsule prepartions
06/25/2003EP1321137A1 Film forming liquid composition
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320613A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320601A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320597A2 Induction of exon skipping in eukaryotic cells
06/25/2003EP1320585A2 Oxidoreductases
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320547A1 Transfer factor from birds eggs
06/25/2003EP1320546A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320386A1 A novel cationic lipopolymer as biocompatible gene delivery agent
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320374A1 Influenza virus binding, sialylated oligosaccharide substance and use thereof
06/25/2003EP1320369A1 A method of analgesia
06/25/2003EP1320366A1 Substituted piperidines as melanocortin receptor agonists
06/25/2003EP1320364A1 The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
06/25/2003EP1320361A1 Method for reducing exacerbations associated with copd
06/25/2003EP1320295A1 Collagen/polysaccharide bilayer matrix
06/25/2003EP1244650B1 Arylamine derivatives and their use as anti-telomerase agent
06/25/2003EP1221845B1 Active ingredient combinations having insecticidal and acaricidal properties
06/25/2003EP1169313B1 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
06/25/2003EP1140019B1 Aerosol formulations for buccal and pulmonary application
06/25/2003EP1019036B1 Use of d-methionine to reduce the toxicity of ototoxic drugs and noise
06/25/2003EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies
06/25/2003EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure
06/25/2003EP0925064B1 5-ANDROSTENE 3 beta,17alpha DIOL AS AN INHIBITOR OF TUMOR GROWTH
06/25/2003EP0910365B1 Growth inhibition and eradication of solid tumors using a prolactin modulator and a photosensitizer
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0808172B1 Combination of angiotensin converting enzyme inhibitor and aldosterone antagonist for the treatment of ventricular hypertrophy
06/25/2003EP0803256B1 Drug for relieving side effects caused by immunosuppressants
06/25/2003EP0802783B1 Topical preparations containing l-arginine
06/25/2003CN1426482A Diagnostics and therapeutics for glaucoma
06/25/2003CN1426468A KCNB: novel potassium channel protein
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426401A Novel, slow-acting betamimetics, method for their production and their use as medicaments
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1426304A Chemical Modification of mammalian urine and blood
06/25/2003CN1426302A Brain, spinal and nerve injure treatment
06/25/2003CN1426301A Compositions for treatment and prevention of cardiovascular diseases
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583301 Lipids
06/24/2003US6583167 Methods and kits for treating and diagnosing leiomyomas
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
06/24/2003US6583149 2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-Dioxolane
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
06/24/2003US6583124 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye
06/24/2003US6583123 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582733 Composition for the treatment of hepatitis including HCV
06/24/2003US6582697 Administering a synthetic conjugate comprising a carbohydrate antigenic determinant and an immunogenic carrier not naturally conjugated with said determinant; tumor prophylaxis and therapy for example
06/24/2003US6582689 Interferon- gamma -inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions
06/24/2003US6582355 Cardiac disease treatment method
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/21/2003CA2414343A1 Film forming liquid composition
06/19/2003WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
06/19/2003WO2003050502A2 Prospective identification and characterization of breast cancer stem cells
06/19/2003WO2003050301A2 Susceptibility locus for schizophrenia
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003050241A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
06/19/2003WO2003050122A2 Mitotic kinesin inhibitors
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050064A2 Mitotic kinesin inhibitors
06/19/2003WO2003050044A1 Electrochemically activated water for the treatment of cystitis
06/19/2003WO2003049804A2 Treatment of genitourinary tract disorders
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049770A1 Use of an h1 antagonist and a safe steroid to treat rhinitis
06/19/2003WO2003049769A2 Method for reducing acne or improving skin tone
06/19/2003WO2003049768A1 Selective anesthetic agents and methods of identifying the same
06/19/2003WO2003049750A1 Method for treating infectious conditions of mucosae and muco-cutaneous tissue
06/19/2003WO2003049746A2 Combination of cytochome p450 dependent protease inhibitors
06/19/2003WO2003049745A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
06/19/2003WO2003049744A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
06/19/2003WO2003049740A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049734A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003WO2003049727A1 Treatment of neoplasia
06/19/2003WO2003049724A1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049697A2 Treatment of glioblastoma with thymosin-alpha 1
06/19/2003WO2003049696A2 Glucosamine organic acid adducts
06/19/2003WO2003049690A2 Hiv integrase inhibitors
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049685A2 Treatment for age-related macular degeneration
06/19/2003WO2003049682A2 Composition and method for treating chronic allograft rejection
1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 1151